Summary
Developed as 'Ordinator' by Laboratoires Dausse in France during the 1960s for treatment of psychasthenia. Fenozolone is structurally related to pemoline and acts as a norepinephrine-dopamine releasing agent with weaker serotonin activity. Clinical imaging studies demonstrate focused sensorimotor activation comparable to fluoxetine with greater sympathetic arousal. Community reports suggest optimal doses of 15-25 mg oral for focused stimulation with minimal anxiety. Higher doses above 40 mg significantly increase cardiovascular strain and anxiety.
Dose Information
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | After Effects |
|---|---|---|---|---|---|
| Oral | 15-45 min | 30-60 min | 1-3 hrs | 1-2 hrs | 2-12 hrs |
| Insufflated | 5-10 min | 15-30 min | 1-3 hrs | 1-2 hrs | 2-12 hrs |
Tolerance
Build-up
develops over days to weeks of regular use
Reset
3–7 days for acute; 1–3 weeks for full reset
Effects
Positive
- Stimulation
- Physical euphoria
- Stamina enhancement
Negative
- Increased heart rate
- Vasoconstriction
- Pupil dilation
- Increased blood pressure
- Nausea
- Teeth grinding
- Sweating
Positive
- Focus enhancement
- Motivation enhancement
- Wakefulness
- Euphoria
- Cognitive euphoria
- Analysis enhancement
- Empathy enhancement
Negative
- Anxiety
- Thought acceleration
- Time distortion
Positive
- Bodily control enhancement
- Increased libido
- Increased music appreciation
- Increased Music Appreciation
- Color enhancement
Negative
- Appetite suppression
- Light sensitivity
- Dehydration
- Appetite Suppression
- Dulled perception